SCHEMBL5316677

SCHEMBL5316677

C[CH]Cc1ccccc1F

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.48
IDO1 P14902 2/20 0.45
AOC3 Q16853 1/20 0.44
LMNA P02545 1/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 3/20 0.39
ACHE P22303 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
THRB P10828 1/20 0.38
CYP2A13 Q16696 1/20 0.37
MEN1 O00255 1/20 0.37
NFE2L2 Q16236 1/20 0.37
NPC1 O15118 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11456607 0.82 TAAR1 (0.56) TAAR1IDO1AOC3LMNAKMT2A
SCHEMBL12954591 0.82 TAAR1 (0.56) TAAR1IDO1AOC3LMNAKMT2A
SCHEMBL12473708 0.78 TAAR1 (0.50) TAAR1IDO1AOC3LMNAKMT2A
SCHEMBL575057 0.78 TAAR1 (0.50) TAAR1IDO1AOC3LMNAKMT2A
SCHEMBL436798 0.77 TAAR1 (0.56) TAAR1IDO1AOC3LMNAKMT2A
SCHEMBL3634562 0.76 TAAR1 (0.48) TAAR1IDO1AOC3LMNAKMT2A
SCHEMBL248425 0.76 TAAR1 (0.48) TAAR1IDO1AOC3LMNAKMT2A
SCHEMBL30079047 0.76 TAAR1 (0.48) TAAR1IDO1AOC3LMNAKMT2A
SCHEMBL20985487 0.76 TAAR1 (0.54) TAAR1IDO1AOC3LMNAKMT2A
SCHEMBL21633667 0.76 TAAR1 (0.48) TAAR1IDO1AOC3LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013139929-A1 NOVEL MEANS AND METHODS FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM, METABOLIC AND CARDIAC DISEASES AND AGING LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2013-09-26 WO claimed
CN-103119031-A Substituted amide compounds ASTELLAS PHARMA INC 2013-05-22 CN claimed
CN-103119031-B Substituted amide compounds ASTELLAS PHARMA INC 2015-01-14 CN disclosed
CN-103929965-A Method of treatment GLAXOSMITHKLINE LLC 2014-07-16 CN disclosed
CN-103732065-A Benzofuran compounds for the treatment of hepatitis c virus infections GLAXO GROUP LTD 2014-04-16 CN disclosed
WO-2013139929-A1 NOVEL MEANS AND METHODS FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM, METABOLIC AND CARDIAC DISEASES AND AGING LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2013-09-26 WO disclosed
CN-103119031-A Substituted amide compounds ASTELLAS PHARMA INC 2013-05-22 CN disclosed
WO-2012163959-A1 INSECTICIDAL COMPOUNDS SYNGENTA PARTICIPATIONS AG (CH) 2012-12-06 WO disclosed
CN-102134214-A Isoindolone compounds and their use as metabotropic glutamate receptor potentiators ASTRAZENECA SWEDEN AB 2011-07-27 CN disclosed
CN-101039907-B Isoindolone compounds and their use as metabotropic glutamate receptor potentiators ASTRAZENECA AB 2011-02-23 CN disclosed
CN-101039907-A Isoindolone compounds and their use as metabotropic glutamate receptor potentiators ASTRAZENECA AB (SE) 2007-09-19 CN disclosed
WO-2007069053-A1 BENZIMIDAZOLE ANTAGONISTS OF THE H-3 RECEPTOR PFIZER PRODUCTS INC. (US) 2007-06-21 WO disclosed
CN-1950089-A Morpholine compounds PFIZER LTD (US) 2007-04-18 CN disclosed
EP-1334976-B1 Novel phosphine compound, transition metal complex containing said compound as ligand and asymetric synthesis catalyst containing said complex TAKASAGO PERFUMERY CO LTD (JP) 2006-03-08 EP disclosed
EP-1334976-A1 Novel phosphine compound, transition metal complex containing said compound as ligand and asymetric synthesis catalyst containing said complex Takasago International Corporation (JP) 2003-08-13 EP disclosed
US-5192767-A Nonphytotoxic BASF AKTIENGESELLSCHAFT (DE) 1993-03-09 US disclosed
EP-0311907-A2 3-Substituted pyridines and fungicides containing them BASF Aktiengesellschaft (DE) 1989-04-19 EP disclosed